Relationship between systemic immune-inflammation index and all-cause mortality in stages IIIB–IV epidermal growth factor receptor-mutated lung adenocarcinoma
Elevated SII is an independent biomarker for predicting ACM in individuals with stages IIIB-IV EGFR-mutated lung adenocarcinoma, with a stronger predictive value in male and older populations.
Authors
- Chi Zhang (ORCID: https://orcid.org/0000-0001-8826-8498)
- Chao Yang (ORCID: https://orcid.org/0009-0005-6077-9153)
Institutions
- Anhui Medical University (CN)
- Anhui Provincial Hospital (CN)
- Anhui Provincial Children's Hospital (CN)
- Anhui Mental Health Center (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-11-05
- DOI
- https://doi.org/10.3389/fendo.2025.1698317
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.05